INTRODUCTION: Increased height and greater adiposity have been linked to an increased risk of many cancer types, though few large studies have examined these associations in glioma. We examined body weight and height as potential risk factors for glioma in a large US-based case-control study. METHODS: The analysis included 1,111 glioma cases and 1,096 community controls. In a structured interview, participants reported their height and weight at 21 years of age, lowest and highest weight in adulthood, and weight 1-5 years in the past. RESULTS: Being underweight at age 21 (BMI < 18.5 kg/m(2)) was inversely associated with the risk of glioma development. This protective association was observed in both men and women, but reached statistical significance in women only (multivariate OR 0.68; 95 % CI 0.48, 0.96). When BMI at age 21 was assessed as a continuous variate, a small but significant increase in risk was observed per unit increase in kg/m(2) (OR 1.04; 95 % CI 1.02, 1.07). Adult height, recent body weight, and weight change in adulthood were not associated with glioma risk. All results were similar among never smokers and were consistent after stratifying by glioma subtype. CONCLUSION: The present data suggest that a low body weight in early adulthood is associated with a reduced risk of glioma later in life. Results are consistent with previous studies in showing no material association of glioma risk with usual adult body weight. The present study does not support any association of adult stature with glioma risk.
INTRODUCTION: Increased height and greater adiposity have been linked to an increased risk of many cancer types, though few large studies have examined these associations in glioma. We examined body weight and height as potential risk factors for glioma in a large US-based case-control study. METHODS: The analysis included 1,111 glioma cases and 1,096 community controls. In a structured interview, participants reported their height and weight at 21 years of age, lowest and highest weight in adulthood, and weight 1-5 years in the past. RESULTS: Being underweight at age 21 (BMI < 18.5 kg/m(2)) was inversely associated with the risk of glioma development. This protective association was observed in both men and women, but reached statistical significance in women only (multivariate OR 0.68; 95 % CI 0.48, 0.96). When BMI at age 21 was assessed as a continuous variate, a small but significant increase in risk was observed per unit increase in kg/m(2) (OR 1.04; 95 % CI 1.02, 1.07). Adult height, recent body weight, and weight change in adulthood were not associated with glioma risk. All results were similar among never smokers and were consistent after stratifying by glioma subtype. CONCLUSION: The present data suggest that a low body weight in early adulthood is associated with a reduced risk of glioma later in life. Results are consistent with previous studies in showing no material association of glioma risk with usual adult body weight. The present study does not support any association of adult stature with glioma risk.
Authors: Kathleen M Egan; L Burton Nabors; Jeffrey J Olson; Alvaro N Monteiro; James E Browning; Melissa H Madden; Reid C Thompson Journal: J Med Genet Date: 2012-06-15 Impact factor: 6.318
Authors: Cari M Kitahara; Sophia S Wang; Beatrice S Melin; Zhaoming Wang; Melissa Braganza; Peter D Inskip; Demetrius Albanes; Ulrika Andersson; Laura E Beane Freeman; Julie E Buring; Tania Carreón; Maria Feychting; Susan M Gapstur; J Michael Gaziano; Graham G Giles; Goran Hallmans; Susan E Hankinson; Roger Henriksson; Ann W Hsing; Christoffer Johansen; Martha S Linet; Roberta McKean-Cowdin; Dominique S Michaud; Ulrike Peters; Mark P Purdue; Nathaniel Rothman; Avima M Ruder; Howard D Sesso; Gianluca Severi; Xiao-Ou Shu; Victoria L Stevens; Kala Visvanathan; Martha A Waters; Emily White; Alicja Wolk; Anne Zeleniuch-Jacquotte; Wei Zheng; Robert Hoover; Joseph F Fraumeni; Nilanjan Chatterjee; Meredith Yeager; Stephen J Chanock; Patricia Hartge; Preetha Rajaraman Journal: Int J Epidemiol Date: 2012-08 Impact factor: 7.196
Authors: Dominique S Michaud; Gerald Bové; Valentina Gallo; Brigitte Schlehofer; Anne Tjønneland; Anja Olsen; Kim Overvad; Christina C Dahm; Brigit Teucher; Heiner Boeing; Annika Steffen; Antonia Trichopoulou; Christina Bamia; Andreas Kyrozis; Carlotta Sacerdote; Claudia Agnoli; Domenico Palli; Rosario Tumino; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H M Peeters; Anne M May; Aurelio Barricarte; Maria-Dolores Chirlaque; Miren Dorronsoro; Maria José Sánchez; Laudina Rodríguez; Eric J Duell; Göran Hallmans; Beatrice S Melin; Jonas Manjer; Signe Borgquist; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Ruth C Travis; Isabelle Romieu; Paolo Vineis; Elio Riboli Journal: Cancer Prev Res (Phila) Date: 2011-06-17
Authors: Gabriella M Anic; Melissa H Madden; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; Renato V Larocca; James E Browning; John D Brockman; Peter A Forsyth; Kathleen M Egan Journal: Cancer Causes Control Date: 2013-08-31 Impact factor: 2.506
Authors: Rebecca B Little; L Burt Nabors; Jeffrey J Olson; Zachary J Thompson; Carrie M Rozmeski; Renato V LaRocca; Peter A Forsyth; Reid C Thompson; Robert A Oster; Sajeel A Chowdhary; Kathleen M Egan Journal: Cancer Causes Control Date: 2017-03-04 Impact factor: 2.506
Authors: Quinn T Ostrom; Maral Adel Fahmideh; David J Cote; Ivo S Muskens; Jeremy M Schraw; Michael E Scheurer; Melissa L Bondy Journal: Neuro Oncol Date: 2019-11-04 Impact factor: 12.300
Authors: Gabriella M Anic; Melissa H Madden; Kelly Sincich; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; James E Browning; Edward Pan; Kathleen M Egan Journal: Eur J Epidemiol Date: 2013-05-17 Impact factor: 8.082
Authors: Cari M Kitahara; Michael Gamborg; Preetha Rajaraman; Thorkild I A Sørensen; Jennifer L Baker Journal: Am J Epidemiol Date: 2014-09-09 Impact factor: 4.897
Authors: Erin M Siegel; L Burton Nabors; Reid C Thompson; Jeffrey J Olson; James E Browning; Melissa H Madden; Gang Han; Kathleen M Egan Journal: J Neurooncol Date: 2013-05-11 Impact factor: 4.130
Authors: Gabriella M Anic; Melissa H Madden; L Burton Nabors; Jeffrey J Olson; Renato V LaRocca; Zachary J Thompson; Shitaldas J Pamnani; Peter A Forsyth; Reid C Thompson; Kathleen M Egan Journal: J Neurooncol Date: 2014-04-04 Impact factor: 4.130
Authors: David J Cote; Mary K Downer; Timothy R Smith; Stephanie A Smith-Warner; Kathleen M Egan; Meir J Stampfer Journal: Cancer Causes Control Date: 2018-06-26 Impact factor: 2.506
Authors: Noah C Peeri; Jordan H Creed; Gabriella M Anic; Reid C Thompson; Jeffrey J Olson; Renato V LaRocca; Sajeel A Chowdhary; John D Brockman; Travis A Gerke; L Burton Nabors; Kathleen M Egan Journal: Cancer Epidemiol Date: 2018-05-25 Impact factor: 2.984